UG Healthcare Corp. Ltd. (8K7) AI Stock Analysis

• Market Cap: S$65.50M
• Dividend Yield: N/A
• Average Volume (3M): 156.89K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.60
• Revenue Growth: 45.55%
• EPS Growth: 90.48%
• Country: SG
• Employees: 898
• Sector: Healthcare
• Sector Strength: 53
• Industry: Medical - Instruments & Supplies
• EPS (TTM): >-0.01
• Shares Outstanding: 623,825,800
• 10 Day Avg. Volume: 75,010
• 30 Day Avg. Volume: 156,890
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 49 Neutral
• Price Target: S$0.00 ▼(-100.00% Downside)

The overall stock score is primarily driven by financial challenges, with declining revenues and negative profitability metrics significantly impacting the score. Technical analysis shows a neutral to slightly bearish trend, while valuation remains poor due to negative earnings and lack of dividend yield. These factors collectively contribute to a below-average stock score.

UG Healthcare Corp. Ltd. Business Overview & Revenue Model

Company Description

UG Healthcare Corp. Ltd. (8K7) is a Singapore-based investment holding company primarily engaged in the manufacturing and distribution of gloves and other personal protective equipment (PPE). The company operates through its various subsidiaries that manage the production, marketing, and distribution of a wide range of glove products, including latex and nitrile gloves, catering to the healthcare, industrial, and food sectors. UG Healthcare is known for its integrated supply chain, which includes manufacturing facilities in Malaysia and an extensive distribution network across multiple countries.

How the Company Makes Money

UG Healthcare Corp. Ltd. generates revenue primarily through the sale of its glove products. The company's revenue streams are largely divided between manufacturing and distribution. In the manufacturing segment, UG Healthcare produces a variety of gloves, including latex, nitrile, and vinyl, which are then sold in bulk to distributors and end-users in the healthcare, industrial, and food sectors. The distribution segment involves the company's own established distribution network, which allows direct access to various markets globally. Additionally, the company benefits from strategic partnerships and collaborations with regional distributors and healthcare providers, which enhance its market reach and sales volume. UG Healthcare's revenue is significantly influenced by global demand for PPE, particularly during health crises such as the COVID-19 pandemic, which saw a surge in demand for medical gloves.

UG Healthcare Corp. Ltd. Financial Statement Overview

Summary

UG Healthcare Corp. Ltd. is facing financial headwinds with declining revenues and negative profitability metrics, suggesting operational inefficiencies or market challenges. While the balance sheet shows solid equity, increasing leverage is a concern. Cash flow struggles highlight the need for strategic operational improvements to enhance liquidity and profitability.

Income Statement

The company has faced a decline in revenue over recent years, dropping significantly from 2021 to 2023. Despite an increase in revenue from 2023 to 2024, profitability remains a challenge with negative EBIT and net income margins. The gross profit margin has improved but remains insufficient to offset operational losses, indicating potential inefficiencies or cost management issues.

Balance Sheet

The balance sheet shows a relatively strong equity base with a healthy equity ratio. However, the debt-to-equity ratio has increased, indicating rising financial leverage. Despite this, the company maintains a strong cash position, which provides some buffer against financial risks.

Cash Flow

The company is experiencing negative operating and free cash flows, reflecting operational challenges and potential cash management issues. This is concerning as negative cash flows persist, despite a minor improvement in free cash flow from 2023 to 2024.

Breakdown	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement
Total Revenue	115.20M	101.13M	232.60M	338.40M	144.21M
Gross Profit	25.87M	1.45M	84.39M	196.16M	42.52M
EBITDA	-3.86M	-24.53M	53.37M	159.46M	21.35M
Net Income	-6.06M	-20.73M	36.80M	118.77M	13.40M
Balance Sheet
Total Assets	226.45M	230.00M	288.04M	268.29M	113.02M
Cash, Cash Equivalents and Short-Term Investments	28.00M	61.74M	100.22M	68.44M	9.29M
Total Debt	43.72M	31.13M	17.98M	16.74M	35.65M
Total Liabilities	65.17M	48.81M	52.98M	73.53M	58.74M
Stockholders Equity	163.39M	180.84M	228.90M	190.64M	52.22M
Cash Flow
Free Cash Flow	-20.71M	-47.17M	31.63M	61.47M	7.70M
Operating Cash Flow	-18.16M	-39.14M	53.95M	81.16M	10.99M
Investing Cash Flow	-22.73M	-8.03M	-21.19M	-18.89M	-2.85M
Financing Cash Flow	8.36M	8.70M	-973.00K	-3.14M	-3.74M

UG Healthcare Corp. Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.10
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:8K7, the sentiment is Negative. The current price of 0.1 is below the 20-day moving average (MA) of 0.11, below the 50-day MA of 0.11, and below the 200-day MA of 0.11, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 43.24 is Neutral, neither overbought nor oversold. The STOCH value of 12.70 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SG:8K7.

UG Healthcare Corp. Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
AP4	67 Neutral	S$1.04B	14.24	16.42%	10.97%	18.55%	-5.89%
Sector *	64 Neutral	S$1.54B	7.05	9.05%	8.07%	18.81%	21.25%
8K7	49 Neutral	S$65.50M	―	-1.20%	―	45.55%	90.48%

UG Healthcare Corp. Ltd. Corporate Events

UG Healthcare Announces Board Changes Following Executive Director’s Retirement

UG Healthcare Corporation Limited has announced changes to its Board of Directors, effective June 25, 2025, due to the retirement of Executive Director Mr. Lee Keck Keong. The company will continue to be led by Joint CEOs, Mr. Lee Jun Yih and Mr. Lee Jun Linn, who will oversee the group’s operations and strategic direction. The Board has expressed gratitude for Mr. Lee’s contributions. The new Board composition includes Wong Fook Choy Sunny as Non-Executive Chairman and Independent Director, along with other directors.